Pyxis Oncology Inc.

11/11/2024 | Press release | Distributed by Public on 11/11/2024 06:10

Pyxis Oncology to Host In Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX 201

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.